Immune Thrombocytopenia
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Hematology and Immunology".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 14668
Special Issue Editors
Interests: wAIHA; immune thrombocytopenia; ITP; multiple myeloma; chemotherapy; acute myeloid leukaemia; leukaemia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts (<100x109/L), whose diagnosis is based on first discarding other conditions that could be associated with thrombocytopenia.
In recent years, new discoveries regarding ITP diagnosis and treatment have been made. Thus, although ITP is still recognized on the basis of an exclusion diagnosis, new lab tools such as those proposed by molecular biology studies have acquired an increasing importance. Furthermore, new drugs such as thrombopoietin (TPO) analogues and spleen tyrosine kinase (Syk) inhibitors have been developed and extensively used in the last years.
Given the growing interest in ITP beyond routine daily clinical practice management, the journal Medicina is launching this Special Issue.
We encourage you and your co-workers to submit articles reporting on ITP. Reviews or original articles dealing with aspects associated with diagnosis, differential diagnosis, management of primary ITP, and therapeutic possibilities, as well as case reports of special interest are welcome. In addition, we warmly invite you to submit articles reporting on less frequent types of ITP, e.g., ITP secondary to autoimmune or infectious diseases and lymphoproliferative disorders, drug-induced ITP, etc.
We look forward to receiving your contributions and realizing an interesting and complete Special Issue!
Dr. Tomás José González-López
Dr. Drew Provan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Immune thrombocytopenia, diagnosis, treatment
- thrombopoietin
- thrombopoietin analogs
- immunosuppression
- eltrombopag
- romiplostim
- rituximab
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.